speb/financial-data huggingface dataset:
OGEN balance_sheet (quarterly, 2025-03-31) — Payables: 772498.00
OGEN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1170932.00
OGEN balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 6106.00
OGEN balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
OGEN balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 385360.00
OGEN income_statement (quarterly, 2025-03-31) — Pretax Income: -2216993.00
OGEN cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -195565.00
OGEN income_statement (quarterly, 2025-03-31) — Research And Development: 341542.00
OGEN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -219003165.00
OGEN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
OGEN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1684685.00
OGEN balance_sheet (quarterly, 2025-03-31) — Share Issued: 715842.00
OGEN cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 2228563.00
OGEN cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -195565.00
OGEN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: -68764.00
OGEN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 137688.00
OGEN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 137688.00
OGEN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
OGEN income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
OGEN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
OGEN balance_sheet (quarterly, 2025-03-31) — Total Assets: 3869111.00
OGEN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 137688.00
OGEN balance_sheet (quarterly, 2025-03-31) — Total Debt: 2554385.00
OGEN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 137688.00
OGEN income_statement (quarterly, 2025-03-31) — Total Expenses: 2026227.00
OGEN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3731423.00
OGEN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 0.00
OGEN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
OGEN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -2026227.00
OGEN income_statement (quarterly, 2025-03-31) — Total Unusual Items: -1842.00
OGEN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -1842.00
OGEN balance_sheet (quarterly, 2025-03-31) — Working Capital: 137688.00
OGEN income_statement (quarterly, 2025-06-30) — +Operating Expense: 1714202.00
OGEN income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
OGEN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 219146662.00
OGEN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 731817.00
OGEN income_statement (quarterly, 2025-06-30) — Basic EPS: -3.10
OGEN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 3421078.00
OGEN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 823.00
OGEN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1973745.00
OGEN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1973745.00
OGEN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -132963.00
OGEN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1314370.00
OGEN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 0.00
OGEN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 0.00
OGEN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 90385.00
OGEN cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 282070.00
OGEN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 372455.00
OGEN cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1447333.00
OGEN balance_sheet (quarterly, 2025-06-30) — Common Stock: 823.00
OGEN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -2127715.00
OGEN cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
OGEN balance_sheet (quarterly, 2025-06-30) — Current Assets: 2139708.00
OGEN balance_sheet (quarterly, 2025-06-30) — Current Debt: 3000000.00
OGEN balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 3000000.00
OGEN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 4267423.00
OGEN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 731817.00
OGEN income_statement (quarterly, 2025-06-30) — Diluted EPS: -3.10
OGEN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -2272035.00
OGEN income_statement (quarterly, 2025-06-30) — EBIT: -1699725.00
OGEN income_statement (quarterly, 2025-06-30) — EBITDA: -1699725.00
OGEN cash_flow (quarterly, 2025-06-30) — End Cash Position: 1973745.00
OGEN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -132963.00
OGEN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1314370.00
OGEN income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -2316.00
OGEN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1264523.00
OGEN income_statement (quarterly, 2025-06-30) — Interest Expense: 572310.00
OGEN income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 572310.00
OGEN income_statement (quarterly, 2025-06-30) — Interest Income: 16793.00
OGEN income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 16793.00
OGEN cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 1592.00
OGEN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 872285.00
OGEN cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
OGEN cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
OGEN cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
OGEN balance_sheet (quarterly, 2025-06-30) — Net Debt: 1026255.00
OGEN income_statement (quarterly, 2025-06-30) — Net Income: -2272035.00
OGEN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -2272035.00
OGEN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -2272035.00
OGEN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -2272035.00
OGEN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -2272035.00
OGEN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -2272035.00
OGEN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -2272035.00
OGEN income_statement (quarterly, 2025-06-30) — Net Interest Income: -555517.00
OGEN cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -132963.00
OGEN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -555517.00
OGEN cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -132963.00
OGEN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -2127715.00
OGEN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -1697409.00
OGEN income_statement (quarterly, 2025-06-30) — Normalized Income: -2269719.00
OGEN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1314370.00
OGEN income_statement (quarterly, 2025-06-30) — Operating Income: -1714202.00
OGEN income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
OGEN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 822927.00
OGEN balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 165963.00
OGEN balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 3000000.00
OGEN income_statement (quarterly, 2025-06-30) — Other Gand A: 1264523.00
OGEN income_statement (quarterly, 2025-06-30) — Other Income Expense: -2316.00
OGEN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 578578.00
OGEN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1267423.00
OGEN balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
OGEN income_statement (quarterly, 2025-06-30) — Pretax Income: -2272035.00
OGEN cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -132963.00
OGEN income_statement (quarterly, 2025-06-30) — Research And Development: 449679.00
OGEN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -221275200.00
OGEN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1264523.00
OGEN balance_sheet (quarterly, 2025-06-30) — Share Issued: 822927.00
OGEN cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 0.00
OGEN cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -132963.00
OGEN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 6632.00
OGEN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -2127715.00
OGEN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -2127715.00
OGEN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
OGEN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
OGEN balance_sheet (quarterly, 2025-06-30) — Total Assets: 2139708.00
OGEN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -2127715.00
OGEN balance_sheet (quarterly, 2025-06-30) — Total Debt: 3000000.00
OGEN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -2127715.00
OGEN income_statement (quarterly, 2025-06-30) — Total Expenses: 1714202.00
OGEN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4267423.00
OGEN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 0.00
OGEN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
OGEN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -1714202.00
OGEN income_statement (quarterly, 2025-06-30) — Total Unusual Items: -2316.00
OGEN income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -2316.00
OGEN balance_sheet (quarterly, 2025-06-30) — Working Capital: -2127715.00
OGEN income_statement (quarterly, 2025-09-30) — +Operating Expense: 3123773.00
OGEN income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
OGEN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 234169098.00
OGEN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 1560909.00
OGEN income_statement (quarterly, 2025-09-30) — Basic EPS: -1.96
OGEN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1973745.00
OGEN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 4127.00
OGEN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 11403766.00
OGEN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 11403766.00
OGEN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 12414536.00
OGEN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -2984515.00
OGEN cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 0.00
OGEN cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 0.00
OGEN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1211849.00
OGEN cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -1135815.00
OGEN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 76034.00
OGEN cash_flow (quarterly, 2025-09-30) — Changes In Cash: 9430021.00
OGEN balance_sheet (quarterly, 2025-09-30) — Common Stock: 4127.00
OGEN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 9831436.00
OGEN cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
OGEN balance_sheet (quarterly, 2025-09-30) — Current Assets: 12705544.00
OGEN balance_sheet (quarterly, 2025-09-30) — Current Debt: 394836.00
OGEN balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 394836.00
OGEN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2874108.00
OGEN balance_sheet (quarterly, 2025-09-30) — Current Notes Payable: 394836.00
OGEN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 1560909.00
OGEN income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.96
OGEN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -3066589.00
OGEN income_statement (quarterly, 2025-09-30) — EBIT: -3059550.00
OGEN income_statement (quarterly, 2025-09-30) — EBITDA: -3059550.00
OGEN cash_flow (quarterly, 2025-09-30) — End Cash Position: 11403766.00
OGEN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 12414536.00
OGEN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -2984515.00
OGEN income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -3919.00
OGEN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2192879.00
OGEN income_statement (quarterly, 2025-09-30) — Interest Expense: 7039.00
OGEN income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 7039.00
OGEN income_statement (quarterly, 2025-09-30) — Interest Income: 68142.00
OGEN income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 68142.00
OGEN cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 7039.00
OGEN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 10226272.00
OGEN cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 15019700.00
OGEN cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 394836.00
OGEN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
OGEN income_statement (quarterly, 2025-09-30) — Net Income: -3066589.00
OGEN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -3066589.00
OGEN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -3066589.00
OGEN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -3066589.00
OGEN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -3066589.00
OGEN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -3066589.00
OGEN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -3066589.00
OGEN income_statement (quarterly, 2025-09-30) — Net Interest Income: 61103.00
OGEN cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -2605164.00
OGEN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 61103.00
OGEN cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -2605164.00
OGEN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 9831436.00
OGEN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -3055631.00
OGEN income_statement (quarterly, 2025-09-30) — Normalized Income: -3062670.00
OGEN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -2984515.00
OGEN income_statement (quarterly, 2025-09-30) — Operating Income: -3123773.00
OGEN income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
OGEN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 4127173.00
OGEN balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1301778.00
OGEN income_statement (quarterly, 2025-09-30) — Other Gand A: 2192879.00
OGEN income_statement (quarterly, 2025-09-30) — Other Income Expense: -3919.00
OGEN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 0.00
OGEN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 2479272.00
OGEN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
OGEN income_statement (quarterly, 2025-09-30) — Pretax Income: -3066589.00
OGEN cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -3000000.00
OGEN income_statement (quarterly, 2025-09-30) — Research And Development: 930894.00
OGEN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -224341789.00
OGEN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2192879.00
OGEN balance_sheet (quarterly, 2025-09-30) — Share Issued: 4127173.00
OGEN cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 394836.00
OGEN cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -3000000.00
OGEN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 6040.00
OGEN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 9831436.00
OGEN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 9831436.00
OGEN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
OGEN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
OGEN balance_sheet (quarterly, 2025-09-30) — Total Assets: 12705544.00
OGEN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 9831436.00
OGEN balance_sheet (quarterly, 2025-09-30) — Total Debt: 394836.00
OGEN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 9831436.00
OGEN income_statement (quarterly, 2025-09-30) — Total Expenses: 3123773.00
OGEN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2874108.00
OGEN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 0.00
OGEN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
OGEN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -3123773.00
OGEN income_statement (quarterly, 2025-09-30) — Total Unusual Items: -3919.00
OGEN income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -3919.00
OGEN balance_sheet (quarterly, 2025-09-30) — Working Capital: 9831436.00
OGEN income_statement (annual, 2025-12-31) — +Operating Expense: 9362503.00
OGEN income_statement (quarterly, 2025-12-31) — +Operating Expense: 2498301.00
OGEN income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
OGEN income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
OGEN balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 53082.00
OGEN balance_sheet (quarterly, 2025-12-31) — Accrued Interest Receivable: 53082.00
OGEN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 234905793.00
OGEN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 234905793.00
OGEN income_statement (annual, 2025-12-31) — Basic Average Shares: 2157076.00
OGEN income_statement (annual, 2025-12-31) — Basic EPS: -4.56
OGEN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 864840.00
OGEN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 11403766.00
OGEN balance_sheet (annual, 2025-12-31) — Capital Stock: 4271.00
OGEN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 4271.00
OGEN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 4399726.00
OGEN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 4399726.00
OGEN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8399726.00
OGEN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8399726.00
OGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 16781273.00
OGEN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -168628.00
OGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -9246387.00
OGEN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2835412.00
OGEN cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 0.00
OGEN cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 0.00
OGEN cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 0.00
OGEN cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 0.00
OGEN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 203144.00
OGEN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -920261.00
OGEN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -1007286.00
OGEN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -313178.00
OGEN cash_flow (annual, 2025-12-31) — Change In Receivables: -53082.00
OGEN cash_flow (annual, 2025-12-31) — Change In Working Capital: -857224.00
OGEN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -1286521.00
OGEN cash_flow (annual, 2025-12-31) — Changes In Cash: 7534886.00
OGEN cash_flow (quarterly, 2025-12-31) — Changes In Cash: -3004040.00
OGEN balance_sheet (annual, 2025-12-31) — Common Stock: 4271.00
OGEN balance_sheet (quarterly, 2025-12-31) — Common Stock: 4271.00
OGEN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 8281405.00
OGEN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 8281405.00
OGEN cash_flow (annual, 2025-12-31) — Common Stock Issuance: 2634190.00
OGEN cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: -1140.00
OGEN balance_sheet (annual, 2025-12-31) — Current Assets: 10067764.00
OGEN balance_sheet (quarterly, 2025-12-31) — Current Assets: 10067764.00
OGEN balance_sheet (annual, 2025-12-31) — Current Debt: 227348.00
OGEN balance_sheet (quarterly, 2025-12-31) — Current Debt: 227348.00
OGEN balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 227348.00
OGEN balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 227348.00
OGEN balance_sheet (annual, 2025-12-31) — Current Liabilities: 1786359.00
OGEN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1786359.00
OGEN balance_sheet (annual, 2025-12-31) — Current Notes Payable: 227348.00
OGEN balance_sheet (quarterly, 2025-12-31) — Current Notes Payable: 227348.00
OGEN income_statement (annual, 2025-12-31) — Diluted Average Shares: 2157076.00
OGEN income_statement (annual, 2025-12-31) — Diluted EPS: -4.56
OGEN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -9842487.00
OGEN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -2286870.00
OGEN income_statement (annual, 2025-12-31) — EBIT: -9193467.00
OGEN income_statement (quarterly, 2025-12-31) — EBIT: -2416326.00
OGEN income_statement (annual, 2025-12-31) — EBITDA: -9193467.00
OGEN income_statement (quarterly, 2025-12-31) — EBITDA: -2416326.00
OGEN cash_flow (annual, 2025-12-31) — End Cash Position: 8399726.00
OGEN cash_flow (quarterly, 2025-12-31) — End Cash Position: 8399726.00
OGEN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 16781273.00
OGEN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -168628.00
OGEN cash_flow (annual, 2025-12-31) — Free Cash Flow: -9246387.00
OGEN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -2835412.00
OGEN income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -13193.00
OGEN income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -5116.00
OGEN income_statement (annual, 2025-12-31) — General And Administrative Expense: 6969845.00
OGEN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1827758.00
OGEN income_statement (annual, 2025-12-31) — Interest Expense: 785930.00
OGEN income_statement (quarterly, 2025-12-31) — Interest Expense: 7454.00
OGEN income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 785930.00
OGEN income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 7454.00
OGEN income_statement (annual, 2025-12-31) — Interest Income: 182229.00
OGEN income_statement (quarterly, 2025-12-31) — Interest Income: 87091.00
OGEN income_statement (annual, 2025-12-31) — Interest Income Non Operating: 182229.00
OGEN income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 87091.00
OGEN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 22353.00
OGEN cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 7454.00
OGEN balance_sheet (annual, 2025-12-31) — Invested Capital: 8508753.00
OGEN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 8508753.00
OGEN cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 17653890.00
OGEN cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: -1140.00
OGEN cash_flow (annual, 2025-12-31) — Issuance Of Debt: 2455911.00
OGEN cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -167488.00
OGEN cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 2634190.00
OGEN cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -1140.00
OGEN income_statement (annual, 2025-12-31) — Net Income: -9842487.00
OGEN income_statement (quarterly, 2025-12-31) — Net Income: -2286870.00
OGEN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -9842487.00
OGEN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -2286870.00
OGEN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -9842487.00
OGEN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -2286870.00
OGEN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -9842487.00
OGEN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2286870.00
OGEN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -9842487.00
OGEN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2286870.00
OGEN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -9842487.00
OGEN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -2286870.00
OGEN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -9842487.00
OGEN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -2286870.00
OGEN income_statement (annual, 2025-12-31) — Net Interest Income: -603701.00
OGEN income_statement (quarterly, 2025-12-31) — Net Interest Income: 79637.00
OGEN cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -872617.00
OGEN cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -167488.00
OGEN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -603701.00
OGEN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 79637.00
OGEN cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 15019700.00
OGEN cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 0.00
OGEN cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -872617.00
OGEN cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -167488.00
OGEN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 8281405.00
OGEN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 8281405.00
OGEN income_statement (annual, 2025-12-31) — Normalized EBITDA: -9180274.00
OGEN income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -2411210.00
OGEN income_statement (annual, 2025-12-31) — Normalized Income: -9829473.42
OGEN income_statement (quarterly, 2025-12-31) — Normalized Income: -2281754.00
OGEN cash_flow (annual, 2025-12-31) — Operating Cash Flow: -9246387.00
OGEN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -2835412.00
OGEN income_statement (annual, 2025-12-31) — Operating Income: -9362503.00
OGEN income_statement (quarterly, 2025-12-31) — Operating Income: -2498301.00
OGEN income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
OGEN income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
OGEN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 4271529.00
OGEN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 4271529.00
OGEN balance_sheet (annual, 2025-12-31) — Other Current Assets: 1614956.00
OGEN balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1614956.00
OGEN income_statement (annual, 2025-12-31) — Other Gand A: 6969845.00
OGEN income_statement (quarterly, 2025-12-31) — Other Gand A: 1827758.00
OGEN income_statement (annual, 2025-12-31) — Other Income Expense: -13193.00
OGEN income_statement (quarterly, 2025-12-31) — Other Income Expense: -5116.00
OGEN cash_flow (annual, 2025-12-31) — Other Non Cash Items: 897577.00
OGEN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 126140.00
OGEN balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 4000000.00
OGEN balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 4000000.00
OGEN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1559011.00
OGEN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1559011.00
OGEN balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
OGEN balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
OGEN cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 15019700.00
OGEN cash_flow (quarterly, 2025-12-31) — Preferred Stock Issuance: 0.00
OGEN income_statement (annual, 2025-12-31) — Pretax Income: -9979397.00
OGEN income_statement (quarterly, 2025-12-31) — Pretax Income: -2423780.00
OGEN balance_sheet (annual, 2025-12-31) — Receivables: 53082.00
OGEN balance_sheet (quarterly, 2025-12-31) — Receivables: 53082.00
OGEN cash_flow (annual, 2025-12-31) — Repayment Of Debt: -3328528.00
OGEN cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
OGEN income_statement (annual, 2025-12-31) — Research And Development: 2392658.00
OGEN income_statement (quarterly, 2025-12-31) — Research And Development: 670543.00
OGEN balance_sheet (annual, 2025-12-31) — Retained Earnings: -226628659.00
OGEN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -226628659.00
OGEN income_statement (annual, 2025-12-31) — Selling General And Administration: 6969845.00
OGEN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1827758.00
OGEN balance_sheet (annual, 2025-12-31) — Share Issued: 4271529.00
OGEN balance_sheet (quarterly, 2025-12-31) — Share Issued: 4271529.00
OGEN cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 2455911.00
OGEN cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: -167488.00
OGEN cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -3328528.00
OGEN cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: 0.00
OGEN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 555747.00
OGEN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 611839.00
OGEN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 8281405.00
OGEN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 8281405.00
OGEN balance_sheet (annual, 2025-12-31) — Tangible Book Value: 8281405.00
OGEN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 8281405.00
OGEN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -179.42
OGEN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
OGEN income_statement (annual, 2025-12-31) — Tax Provision: -136910.00
OGEN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.01
OGEN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
OGEN balance_sheet (annual, 2025-12-31) — Total Assets: 10067764.00
OGEN balance_sheet (quarterly, 2025-12-31) — Total Assets: 10067764.00
OGEN balance_sheet (annual, 2025-12-31) — Total Capitalization: 8281405.00
OGEN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 8281405.00
OGEN balance_sheet (annual, 2025-12-31) — Total Debt: 227348.00
OGEN balance_sheet (quarterly, 2025-12-31) — Total Debt: 227348.00
OGEN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 8281405.00
OGEN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 8281405.00
OGEN income_statement (annual, 2025-12-31) — Total Expenses: 9362503.00
OGEN income_statement (quarterly, 2025-12-31) — Total Expenses: 2498301.00
OGEN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1786359.00
OGEN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1786359.00
OGEN balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 0.00
OGEN balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 0.00
OGEN balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
OGEN balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
OGEN income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -9362503.00
OGEN income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -2498301.00
OGEN income_statement (annual, 2025-12-31) — Total Unusual Items: -13193.00
OGEN income_statement (quarterly, 2025-12-31) — Total Unusual Items: -5116.00
OGEN income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -13193.00
OGEN income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -5116.00
OGEN balance_sheet (annual, 2025-12-31) — Working Capital: 8281405.00
OGEN balance_sheet (quarterly, 2025-12-31) — Working Capital: 8281405.00
OGEN income_statement (quarterly, 2026-03-31) — +Operating Expense: 2255927.00
OGEN income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
OGEN balance_sheet (quarterly, 2026-03-31) — Accrued Interest Receivable: 0.00
OGEN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 235007285.00
OGEN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 4300980.00
OGEN income_statement (quarterly, 2026-03-31) — Basic EPS: -0.51
OGEN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 4399726.00
OGEN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4375.00
OGEN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 6107078.00
OGEN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 6107078.00
OGEN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -92004.00
OGEN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 4000000.00
OGEN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -2200644.00
OGEN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -307267.00
OGEN cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 232398.00
OGEN cash_flow (quarterly, 2026-03-31) — Change In Receivables: 53082.00
OGEN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -21787.00
OGEN cash_flow (quarterly, 2026-03-31) — Changes In Cash: 1707352.00
OGEN balance_sheet (quarterly, 2026-03-31) — Common Stock: 4375.00
OGEN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 6181758.00
OGEN cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 79210.00
OGEN balance_sheet (quarterly, 2026-03-31) — Current Assets: 7489636.00
OGEN balance_sheet (quarterly, 2026-03-31) — Current Debt: 56134.00
OGEN balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 56134.00
OGEN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1307878.00
OGEN balance_sheet (quarterly, 2026-03-31) — Current Notes Payable: 56134.00
OGEN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 4300980.00
OGEN income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.51
OGEN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -2201243.00
OGEN income_statement (quarterly, 2026-03-31) — EBIT: -2220141.00
OGEN income_statement (quarterly, 2026-03-31) — EBITDA: -2220141.00
OGEN cash_flow (quarterly, 2026-03-31) — End Cash Position: 6107078.00
OGEN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -92004.00
OGEN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -2200644.00
OGEN income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -5090.00
OGEN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1610457.00
OGEN income_statement (quarterly, 2026-03-31) — Interest Expense: 3727.00
OGEN income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3727.00
OGEN income_statement (quarterly, 2026-03-31) — Interest Income: 40876.00
OGEN income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 40876.00
OGEN cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 3727.00
OGEN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 6237892.00
OGEN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 4000000.00
OGEN cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 79210.00
OGEN cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
OGEN cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 79210.00
OGEN income_statement (quarterly, 2026-03-31) — Net Income: -2201243.00
OGEN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -2201243.00
OGEN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -2201243.00
OGEN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -2201243.00
OGEN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -2201243.00
OGEN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -2201243.00
OGEN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -2201243.00
OGEN income_statement (quarterly, 2026-03-31) — Net Interest Income: 37149.00
OGEN cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 4000000.00
OGEN cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -171214.00
OGEN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 37149.00
OGEN cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -171214.00
OGEN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 6181758.00
OGEN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -2215051.00
OGEN income_statement (quarterly, 2026-03-31) — Normalized Income: -2196204.78
OGEN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -2200644.00
OGEN income_statement (quarterly, 2026-03-31) — Operating Income: -2255927.00
OGEN income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
OGEN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 4375729.00
OGEN balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1382558.00
OGEN income_statement (quarterly, 2026-03-31) — Other Gand A: 1610457.00
OGEN income_statement (quarterly, 2026-03-31) — Other Income Expense: -5090.00
OGEN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 5000.00
OGEN balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 0.00
OGEN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1251744.00
OGEN balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
OGEN income_statement (quarterly, 2026-03-31) — Pretax Income: -2223868.00
OGEN balance_sheet (quarterly, 2026-03-31) — Receivables: 0.00
OGEN cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -171214.00
OGEN income_statement (quarterly, 2026-03-31) — Research And Development: 645470.00
OGEN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -228829902.00
OGEN cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 4000000.00
OGEN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1610457.00
OGEN balance_sheet (quarterly, 2026-03-31) — Share Issued: 4375729.00
OGEN cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 0.00
OGEN cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -171214.00
OGEN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 17386.00
OGEN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 6181758.00
OGEN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 6181758.00
OGEN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -51.78
OGEN income_statement (quarterly, 2026-03-31) — Tax Provision: -22625.00
OGEN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.01
OGEN balance_sheet (quarterly, 2026-03-31) — Total Assets: 7489636.00
OGEN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 6181758.00
OGEN balance_sheet (quarterly, 2026-03-31) — Total Debt: 56134.00
OGEN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 6181758.00
OGEN income_statement (quarterly, 2026-03-31) — Total Expenses: 2255927.00
OGEN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1307878.00
OGEN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 0.00
OGEN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
OGEN income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -2255927.00
OGEN income_statement (quarterly, 2026-03-31) — Total Unusual Items: -5090.00
OGEN income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -5090.00
OGEN balance_sheet (quarterly, 2026-03-31) — Working Capital: 6181758.00
OGI income_statement (annual, 2021-08-31) — +Operating Expense: 44440000.00
OGI income_statement (annual, 2021-08-31) — +Total Revenue: 79163000.00
OGI balance_sheet (annual, 2021-08-31) — Accounts Payable: 18952000.00
OGI balance_sheet (annual, 2021-08-31) — Accounts Receivable: 20205000.00
OGI balance_sheet (annual, 2021-08-31) — Accumulated Depreciation: -61041000.00
OGI balance_sheet (annual, 2021-08-31) — Allowance For Doubtful Accounts Receivable: -710000.00
OGI cash_flow (annual, 2021-08-31) — Asset Impairment Charge: 6946000.00
OGI income_statement (annual, 2021-08-31) — Basic Average Shares: 64029982.00
OGI income_statement (annual, 2021-08-31) — Basic EPS: -2.04
OGI cash_flow (annual, 2021-08-31) — Beginning Cash Position: 24600000.00
OGI balance_sheet (annual, 2021-08-31) — Buildings And Improvements: 135763000.00
OGI cash_flow (annual, 2021-08-31) — Capital Expenditure: -12295000.00
OGI balance_sheet (annual, 2021-08-31) — Capital Lease Obligations: 5635000.00
OGI balance_sheet (annual, 2021-08-31) — Capital Stock: 730803000.00
OGI balance_sheet (annual, 2021-08-31) — Cash And Cash Equivalents: 55365000.00
OGI balance_sheet (annual, 2021-08-31) — Cash Cash Equivalents And Short Term Investments: 183555000.00
OGI cash_flow (annual, 2021-08-31) — Cash Dividends Paid: 0.00
OGI balance_sheet (annual, 2021-08-31) — Cash Financial: 55365000.00
OGI cash_flow (annual, 2021-08-31) — Cash Flow From Continuing Financing Activities: 174463000.00
OGI cash_flow (annual, 2021-08-31) — Cash Flow From Continuing Investing Activities: -115109000.00
OGI cash_flow (annual, 2021-08-31) — Cash Flow From Continuing Operating Activities: -28589000.00
OGI cash_flow (annual, 2021-08-31) — Change In Account Payable: 2062000.00
OGI cash_flow (annual, 2021-08-31) — Change In Inventory: 18946000.00
OGI cash_flow (annual, 2021-08-31) — Change In Other Current Liabilities: 0.00
OGI cash_flow (annual, 2021-08-31) — Change In Other Working Capital: -542000.00
OGI cash_flow (annual, 2021-08-31) — Change In Payable: 2062000.00
OGI cash_flow (annual, 2021-08-31) — Change In Payables And Accrued Expense: 2062000.00
OGI cash_flow (annual, 2021-08-31) — Change In Prepaid Assets: -542000.00
OGI cash_flow (annual, 2021-08-31) — Change In Receivables: -6007000.00
OGI cash_flow (annual, 2021-08-31) — Change In Working Capital: 14459000.00
OGI cash_flow (annual, 2021-08-31) — Changes In Account Receivables: -6007000.00
OGI cash_flow (annual, 2021-08-31) — Changes In Cash: 30765000.00
OGI balance_sheet (annual, 2021-08-31) — Common Stock: 730803000.00
OGI balance_sheet (annual, 2021-08-31) — Common Stock Equity: 479805000.00
OGI cash_flow (annual, 2021-08-31) — Common Stock Issuance: 284876000.00
OGI balance_sheet (annual, 2021-08-31) — Construction In Progress: 2092000.00
OGI income_statement (annual, 2021-08-31) — Cost Of Revenue: 107562000.00
OGI balance_sheet (annual, 2021-08-31) — Current Assets: 260615000.00
OGI balance_sheet (annual, 2021-08-31) — Current Capital Lease Obligation: 984000.00
OGI balance_sheet (annual, 2021-08-31) — Current Debt: 80000.00
OGI balance_sheet (annual, 2021-08-31) — Current Debt And Capital Lease Obligation: 1064000.00
OGI balance_sheet (annual, 2021-08-31) — Current Liabilities: 26266000.00
OGI balance_sheet (annual, 2021-08-31) — Current Provisions: 2750000.00
OGI cash_flow (annual, 2021-08-31) — Deferred Income Tax: 0.00
OGI cash_flow (annual, 2021-08-31) — Deferred Tax: 0.00
OGI cash_flow (annual, 2021-08-31) — Depreciation Amortization Depletion: 31033000.00
OGI income_statement (annual, 2021-08-31) — Depreciation Amortization Depletion Income Statement: 2471000.00
OGI cash_flow (annual, 2021-08-31) — Depreciation And Amortization: 31033000.00
OGI income_statement (annual, 2021-08-31) — Depreciation And Amortization In Income Statement: 2471000.00
OGI balance_sheet (annual, 2021-08-31) — Derivative Product Liabilities: 37527000.00
OGI income_statement (annual, 2021-08-31) — Diluted Average Shares: 64029982.00
OGI income_statement (annual, 2021-08-31) — Diluted EPS: -2.04
OGI income_statement (annual, 2021-08-31) — Diluted NI Availto Com Stockholders: -130704000.00
OGI income_statement (annual, 2021-08-31) — EBIT: -127744000.00
OGI income_statement (annual, 2021-08-31) — EBITDA: -96711000.00
OGI income_statement (annual, 2021-08-31) — Earnings From Equity Interest: -1118000.00
OGI cash_flow (annual, 2021-08-31) — Earnings Losses From Equity Investments: 1118000.00
OGI cash_flow (annual, 2021-08-31) — End Cash Position: 55365000.00
OGI income_statement (annual, 2021-08-31) — Excise Taxes: 30696000.00
OGI cash_flow (annual, 2021-08-31) — Financing Cash Flow: 174463000.00
OGI balance_sheet (annual, 2021-08-31) — Finished Goods: 7794000.00
OGI cash_flow (annual, 2021-08-31) — Free Cash Flow: -40884000.00
OGI cash_flow (annual, 2021-08-31) — Gain Loss On Investment Securities: 28974000.00
OGI cash_flow (annual, 2021-08-31) — Gain Loss On Sale Of PPE: 2426000.00
OGI income_statement (annual, 2021-08-31) — Gain On Sale Of Ppe: -2426000.00
OGI income_statement (annual, 2021-08-31) — Gain On Sale Of Security: -28974000.00
OGI balance_sheet (annual, 2021-08-31) — Gains Losses Not Affecting Retained Earnings: 24646000.00
OGI income_statement (annual, 2021-08-31) — General And Administrative Expense: 30664000.00
OGI balance_sheet (annual, 2021-08-31) — Goodwill: 14321000.00
OGI balance_sheet (annual, 2021-08-31) — Goodwill And Other Intangible Assets: 17046000.00
OGI balance_sheet (annual, 2021-08-31) — Gross Accounts Receivable: 20915000.00
OGI balance_sheet (annual, 2021-08-31) — Gross PPE: 296980000.00
OGI income_statement (annual, 2021-08-31) — Gross Profit: -28399000.00
OGI income_statement (annual, 2021-08-31) — Impairment Of Capital Assets: 10834000.00
OGI balance_sheet (annual, 2021-08-31) — Income Tax Payable: 0.00
OGI income_statement (annual, 2021-08-31) — Interest Expense: 2960000.00
OGI income_statement (annual, 2021-08-31) — Interest Expense Non Operating: 2960000.00
OGI cash_flow (annual, 2021-08-31) — Interest Paid Cff: -2397000.00
OGI balance_sheet (annual, 2021-08-31) — Inventory: 48818000.00
OGI balance_sheet (annual, 2021-08-31) — Invested Capital: 480115000.00
OGI cash_flow (annual, 2021-08-31) — Investing Cash Flow: -115109000.00
OGI balance_sheet (annual, 2021-08-31) — Investments And Advances: 5028000.00
OGI balance_sheet (annual, 2021-08-31) — Investmentsin Associatesat Cost: 5028000.00
OGI cash_flow (annual, 2021-08-31) — Issuance Of Capital Stock: 284876000.00
OGI cash_flow (annual, 2021-08-31) — Issuance Of Debt: 0.00
OGI balance_sheet (annual, 2021-08-31) — Land And Improvements: 4075000.00
OGI balance_sheet (annual, 2021-08-31) — Loans Receivable: 250000.00
OGI balance_sheet (annual, 2021-08-31) — Long Term Capital Lease Obligation: 4651000.00
OGI balance_sheet (annual, 2021-08-31) — Long Term Debt: 230000.00
OGI balance_sheet (annual, 2021-08-31) — Long Term Debt And Capital Lease Obligation: 4881000.00
OGI cash_flow (annual, 2021-08-31) — Long Term Debt Issuance: 0.00
OGI cash_flow (annual, 2021-08-31) — Long Term Debt Payments: -116403000.00
OGI balance_sheet (annual, 2021-08-31) — Long Term Equity Investment: 5028000.00
OGI cash_flow (annual, 2021-08-31) — Net Business Purchase And Sale: -2539000.00
OGI cash_flow (annual, 2021-08-31) — Net Common Stock Issuance: 284876000.00
OGI income_statement (annual, 2021-08-31) — Net Income: -130704000.00
OGI income_statement (annual, 2021-08-31) — Net Income Common Stockholders: -130704000.00
OGI income_statement (annual, 2021-08-31) — Net Income Continuous Operations: -130704000.00
OGI income_statement (annual, 2021-08-31) — Net Income From Continuing And Discontinued Operation: -130704000.00
OGI income_statement (annual, 2021-08-31) — Net Income From Continuing Operation Net Minority Interest: -130704000.00
OGI cash_flow (annual, 2021-08-31) — Net Income From Continuing Operations: -130704000.00